On January 2, 2018, Alder BioPharmaceuticals, Inc. entered into an amendment to the offer letter by and between the company and Elisabeth Sandoval, dated July 26, 2016, pursuant to which Ms. Sandoval was promoted to Chief Commercial Officer and Executive Vice President of Corporate Strategy, effective as of January 1, 2018.